V ascular endothelium represents the first line of defense against stress stimuli guarding the integrity of the vasculature. As such, disruption of endothelial homeostasis is intimately associated with a host of cardiovascular disorders, including atherosclerosis, cardiac infarction, and hypoxic pulmonary hypertension (HPH).
V ascular endothelium represents the first line of defense against stress stimuli guarding the integrity of the vasculature. As such, disruption of endothelial homeostasis is intimately associated with a host of cardiovascular disorders, including atherosclerosis, cardiac infarction, and hypoxic pulmonary hypertension (HPH). 1 Endothelial injury in HPH is reflected by persistent vessel constriction, accumulation of reactive oxygen species, accelerated synthesis and deposition of extracellular matrix proteins, and build-up of proinflammatory milieu. At the transcriptional level, these phenotypic alterations were accompanied by a profound shift in the endothelial transcriptome. 2 Expression of adhesion molecules, for instance, is upregulated by chronic hypoxia to sustain a prolonged and stronger interaction between leukocytes and the vessel wall, representing a hallmark event that defines the intensity of proinflammatory response associated with HPH.
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in endothelial cells to promote the synthesis of ICAM-1, 7 VCAM-1, 8 and E-selectin. 9 Many details regarding NF-κB-dependent CAM transactivation in the context of HPH including the possible involvement of the epigenetic machinery, however, remain to be inked out.
MKL1, variously termed MRTF-A or MAL, is a transcriptional modulator initially discovered as a cofactor for SRF participating in the regulation of smooth muscle cell-specific genes. 10, 11 Several studies have implicated MKL1/MRTF-A in transcriptional regulation in endothelial cells, 12 epithelial cells, 13 platelets, 14 and fibroblast cells. 15, 16 One key characteristics of MKL1/MRTF-A is its ability to engage components of the epigenetic machinery, which include histone acetyltransferase, 17 histone demethylase, 18 and chromatin remodeling protein, 19 ,20 supporting a role for MKL1/MRTF-A as an epigenetic coordinator bridging sequence-specific transcription factors and the chromatin-altering franchise. Mounting evidence has suggested that MKL1/MRTF-A might act as a stress protein mediating cellular compensatory/decompensatory response to injurious signals. Here, we report that MKL1/MRTF-A deficiency ameliorates HPH in mice paralleling a decrease in CAM expression in the lungs. MKL1/ MRTF-A facilitates NF-κB-dependent CAM transactivation in response to hypoxic stress by recruiting a histone H3 lysine 4 (H3K4) methyltransferase complex, the silencing of which is sufficient to stall the pathogenesis of HPH. Therefore, our data portray MKL1/MRTF-A as a key factor in HPH by steering the epigenetic activation of adhesion molecules.
Methods
Methods are available in the online-only Data Supplement.
Results

MKL1 Deficiency Ameliorates HPH in Mice
To verify whether MKL1/MRTF-A, by virtue of activating the transcription of adhesion molecules in vascular endothelial cells, could play a role in the pathogenesis of HPH, we first compared the response of wild-type (WT) and MKL1/MRTF-A-deficient (knockout) mice to the challenge of hypoxic stress. As shown in Figure 1A and 1B, following 3 weeks of exposure to 10% O 2 , WT mice developed HPH as evidenced by the increase in right ventricular systolic pressure and right ventricular weight. On the contrary, knockout mice exhibited a less severe phenotype. In addition, vascular remodeling was more prominent in WT mice than in knockout mice under hypoxic conditions as evaluated by the thickness of the pulmonary vessel wall and neomuscularization ( Figure S1A -S1D in the online-only Data Supplement). Hypoxia resulted in a marked induction of adhesion molecules in the lungs in WT mice, which was significantly diminished in the absence of MKL1/MRTF-A ( Figure 1C and 1D) . Consequently, there was a decrease in the adhesion of circulating immune cells, including CD3+ T lymphocyte, CD45+ leukocyte, and F4/80+ macrophage, in MKL1/MRTF-A knockout mice when compared with that in WT mice ( Figure 1E ). We also noticed a decrease in the levels of several proinflammatory mediators, including interleukin-6, interleukin-1, and monocyte chemoattractant protein 1, in the lung homogenates ( Figure S1E and S1F) and bronchoalveolar lavage fluid ( Figure S1G ) in the knockout mice. Flow cytometry also revealed that immune infiltrates were significantly downregulated in the bronchoalveolar lavage fluid in knockout mice when compared with that in WT mice under hypoxic conditions ( Figure S1H ).
To tackle the question whether mice with endothelialspecific depletion of MKL1/MRTF-A could phenocopy mice with germ-line MKL1/MRTF-A deletion in terms of hypoxic pulmonary hypertension, we used a recently validated lentiviral system carrying MKL1/MRTF-A targeting short hairpin RNA (Endo-shMKL1) driven by the Tie2 gene promoter to specifically knockdown MKL1/MRTF-A in the endothelium. 21 Of interest, endothelial MKL1/MRTF-A depletion led to a decrease in RSVP ( Figure S2A ) and right ventricular weight ( Figure S2B ), which accompanied a simultaneous downregulation of adhesion molecules in the lungs under hypoxic conditions ( Figure S2C ). Similarly, levels of proinflammatory mediators were reduced in the lungs ( Figure S2D and S2E) and in the bronchoalveolar lavage fluid ( Figure S2F ), so were the immune infiltrates in the bronchoalveolar lavage fluid ( Figure S2G ). Therefore, MKL1/MRTF-A deficiency, likely MKL1/MRTF-A in the endothelium, ameliorates HPH in mice in conjunction with reduced CAM expression and pulmonary inflammation.
MKL1 Contributes to Hypoxia-Induced CAM Transactivation
Having observed that the suppression of HPH in mice by MKL1/MRTF-A ablation was accompanied by decelerated synthesis of CAMs in the lungs, we hypothesized that MKL1/ MRTF-A might mediate hypoxia-induced CAM transactivation. Indeed, MKL1/MRTF-A activated promoter activities of ICAM-1, VCAM-1, and E-selectin genes in endothelial cells in a dose-dependent manner ( Figure S3A ). Overexpression of MKL1/MRTF-A potentiated transcriptional activation of adhesion molecules by hypoxia (Figure 2A-2C ). In addition, there was a clear synergy between MKL1/MRTF-A overexpression and hypoxia in the activation of endogenous levels of adhesion molecules ( Figure 2D and 2E). As a result, adhesion of leukocytes to endothelial cells was markedly enhanced ( Figure S3B ).
On the contrary, interfering with MKL1/MRTF-A activity with either dominant negative mutation ( Figure S3C and S3E) or short hairpin RNA-mediated knockdown attenuated CAM activation in response to hypoxia ( Figure S3D ). In addition, induction of endogenous message levels of adhesion molecules by hypoxia was markedly alleviated when cells were depleted of MKL1/MRTF-A with different pairs of small interfering RNA (Figure 2F and 2G; Figure S3F -S3H). Consequently, adhesion of leukocyte to endothelial cells was attenuated ( Figure 2H ).
Because previous investigations suggest that the small G-protein RhoA is required for MKL1/MRTF-A activation, 11, 12 we probed the role of RhoA in hypoxia-induced CAM transactivation. Knockdown of RhoA ( Figure S4A for efficiency) attenuated promoter activities ( Figure S4B ), message levels ( Figure S4C ), and protein levels ( Figure S4D ) of adhesion molecules in response to hypoxia. Cumulatively, these led to a reduction in leukocyte adhesion to endothelial cells in vitro (Figrue S4E). Taken together, these data suggest that MKL1/MRTF-A is a key modulator of CAM gene upregulation in endothelial cells under hypoxic stress possibly acting downstream of RhoA.
Hypoxia Stimulates the Recruitment of MKL1 to CAM Promoters
We have previously shown that MKL1/MRTF-A is recruited to the ICAM-1 promoter by NF-κB/p65 in response to increased intracellular levels of oxidized low-density lipoprotein.
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Figure 1. Megakaryocytic leukemia 1 (MKL1) deficiency ameliorates hypoxic pulmonary hypertension (HPH) and normalizes the expression of adhesion molecules in mice. MKL1-deficient (knockout [KO] ) and age/sex-matched control C57/BL mice were allowed to develop HPH as described in Methods in the online-only Data Supplement. Right ventricular (RV) hypertrophy was evaluated by RV systolic pressure (SP; A) and RV/left ventricle (LV)+S (B). RVSP and RV/LV+S were significantly lower in KO mice when compared with that in WT mice. C and D, Expression of cell adhesion molecules (CAM) was measured by quantitative polymerase chain reaction (C) and Western (D). CAM expression was downregulated in KO mice. Protein quantifications were performed with Image Pro based on 3 independent experiments. n=3 to 5 mice per group. E, Representative images of immunofluorescence staining of pulmonary vessels (50-100 μm) with indicated antibodies; scale bar, 20 μm. Arrows show immune cells adhered to the endothelium. Quantifications were performed using Image Pro and data are expressed as relative adhesion. n=3-5 mice per group. ICAMs indicates intercellular adhesion molecules; VCAMs, vascular cell adhesion molecules; and WT, wild-type.
Therefore, we probed whether hypoxia could promote the occupancy of MKL1/MRTF-A on CAM promoters. As shown in Figrue 3A, there was more MKL1/MRTF-A binding to the same region where p65 binds on all 3 CAM promoters in cells challenged with 1% O 2 . In contrast, little binding was detected in the coding regions of these promoters (data not shown). Moreover, MKL1/MRTF-A binding on the CAM promoters was enhanced in the lungs of HPH mice when compared with the control mice ( Figure 3B ). More important, hypoxia stimulated the interaction between MKL1/MRTF-A and p65 on the CAM promoters ( Figure 3C ). Knockdown of endogenous p65 by siRNA markedly reduced the binding of MKL1/MRTF-A on all 3 promoters ( Figure 3D ). Together, these data suggest that consistent with its role as a potent transactivator of CAM genes, MKL1/MRTF-A occupancy on the CAM promoters was enhanced by hypoxia in a p65-dependent manner. We also found that RhoA silencing suppressed MKL1/MRTF-A binding ( Figure S5A ) and disrupted MKL1-p65 interaction ( Figure S5B ) on CAM promoters under hypoxic conditions, consistent with the fact that RhoA is required for CAM induction by hypoxia.
MKL1 Coordinates Epigenetic Alterations on Target Promoters by Recruiting an H3K4 Methyltransferase Complex
Hypoxia-induced transactivation is associated with enhanced assembly of the basic transcriptional machinery and dynamic histone modifications surrounding the promoter region of genes. 22 We sought to determine how MKL1/MRTF-A would contribute to this process. There was a significant increase in the occupancy of RNA polymerase II on the CAM promoters after hypoxic stress accompanied by elevated levels of acetylated histones H3 and H4, as well as dimethylated and trimethylated H3K4, all of which were blocked by siRNA-mediated silencing of MKL1/MRTF-A ( Figure 4A-4C ). In contrast, monomethylated H3K4 was not altered. Neither were global levels of modified histones affected ( Figure S6C ). More importantly, acetylated histone H3 (Figrue S6A), acetylated histone H4 (Figrue S6B), dimethylated H3K4 (Figre 4D), and trimethylated H3K4 ( Figure 4E ) levels were significantly decreased in the lungs of knockout mice as opposed to WT mice, indicating that MKL1/MRTF-A might be wired to the epigenetic circuit by orchestrating histone modifications. RhoA depletion, on the contrary, prevented the deposition of active histone marks on the CAM promoters ( Figure S7A-S7D) .
The observation that MKL1/MRTF-A loss-of-function caused the erasure of H3K4 methylation on CAM promoters raised an intriguing possibility that MKL1/MRTF-A might be interacting with and recruiting an H3K4 methyltransferase complex. Through proteomic screening, we have identified ASH2, a key component of the mammalian complex of proteins associated with SET (COMPASS)/COMPASSlike H3K4 methyltransferase complex, as a binding partner for MKL1/MRTF-A (manuscript under consideration elsewhere). The interaction between ASH2 and MKL1/MRTF-A was confirmed by coimmunoprecipitation ( Figure 5A ). We also observed an interaction between MKL1/MRTF-A and WDR5, 23 which is required for the function of the H3K4 methyltransferase complex similar to ASH2 ( Figure S8A ). Occupancy of ASH2 ( Figure 5B ) and WDR5 (Figrue S8C) on the CAM promoters was increased by hypoxia paralleling the recruitment of and SET1, the catalytic unit of COMPASS.
Meanwhile, occupancies of COMPASS proteins on the CAM promoters were also downregulated by RhoA knockdown ( Figure S9 ). Thus, MKL1/MRTF-A orchestrates epigenetic regulation of CAM transactivation in response to hypoxia by helping assemble an H3K4 methyltransferase complex on the CAM promoters.
COMPASS Proteins Participate in CAM Transactivation by Hypoxia
Next, we assessed the role of ASH2, WDR5, and SET1 in CAM transactivation-mediated by hypoxia/MKL1. Coexpression of ASH2, WDR5, or SET1 with MKL1/MRTF-A enhanced the promoter activities of ICAM-1 ( Figure 6A ), VCAM-1 ( Figure 6B ), Figure 5 . Megakaryocytic leukemia 1 (MKL1) interacts with a histone H3 lysine 4 methyltransferase complex. A, Whole cell lysates extracted from human umbilical vein endothelial cells (HUVECs) were immunoprecipitated with indicated antibodies. B, EAhy92.6/ HUVECs were exposed to 1% O 2 and harvested at indicated time points. Chromatin immunoprecipitation (ChIP) assays were performed with indicated antibodies. Hypoxia enhanced ASH2 binding on cell adhesion molecules (CAM) promoters in vitro. C, C57/BL mice were induced to develop hypoxic pulmonary hypertension (HPH) as described in Methods in the online-only Data Supplement. ChIP assays were performed using lung lysates with anti-ASH2. Hypoxia enhanced ASH2 binding on CAM promoters in vivo. D, EAhy92.6/HUVECs were exposed to 1% O 2 for 24 hours. Re-ChIP assays were performed with indicated antibodies. Hypoxia enhanced MKL1-ASH2 interaction on CAM promoters in vitro. E, EAhy92.6/HUVECs were transfected with siMKL1 or scrambled RNA (SCR) followed by exposure to 1% O 2 . ChIP assays were performed with anti-ASH2. MKL1 knockdown abrogated ASH2 binding on CAM promoters in vitro.
and E-selectin ( Figure 6C ) genes under normoxic conditions. Meanwhile, ASH2, WDR5, and SET1 also potentiated the promoter activities under hypoxic conditions ( Figure 6D ). On the contrary, knockdown of individual COMPASS components ( Figure S10A for validation) normalized endogenous CAM expression in hypoxia-treated endothelial cells ( Figure 6E and Endothelial-specific depletion of ASH2 and WDR5 attenuates hypoxic pulmonary hypertension (HPH) in mice. C57/BL6 mice were injected via tail vein lentiviral particles carrying endothelial-specific shRNA targeting ASH2 or WDR5. Right ventricular (RV) hypertrophy was evaluated by RV systolic pressure (SP; A) and RV/left ventricle (LV)+S (B). Endothelial-specific silencing of ASH2/WDR5 suppressed RSVP and RV/LV+S in mice. C and D, Expression of cell adhesion molecule (CAM) in the lungs were measured by quantitative polymerase chain reaction (C) and Western (D). n=3 for each group. Endothelial-specific silencing of ASH2/WDR5 repressed CAM expression in the lungs in mice. Protein quantifications were performed with Image Pro based on 3 independent experiments. n=3 to 5 mice per group. E and F, Chromatin immunoprecipitation (ChIP) assays were performed using lung lysates from indicated groups with anti-dimethylated histone H3 lysine 4 (H3K4Me2; E) or anti-trimethylated histone H3 lysine 4 (H3K4Me3; F). Endothelial-specific silencing of ASH2/WDR5 erased H3K4 methylation on CAM promoters in the lungs in mice. G, Representative images of immunofluorescence staining of pulmonary vessels (50-100 μm) with indicated antibodies; scale bar, 20 μm. Arrows show immune cells adhered to the endothelium. Quantifications were performed using Image Pro, and data are expressed as relative adhesion. n=3 to 5 mice per group. H, A model depicting the mode of action for MKL1 in the pathogenesis of HPH. ICAMs indicates intercellular adhesion molecules; SCR, scrambled RNA; and VCAM, vascular cell adhesion molecules 6F). As a result, endothelial-leukocyte interaction was significantly diminished ( Figure 6G ). Together, these data suggest that COMPASS proteins play essential roles in hypoxia-induced, MKL1/MRTF-A-dependent CAM transactivation.
Targeted Depletion of ASH2 and WDR5 in the Endothelium Averts HPH in Mice
Finally, we asked whether endothelial-specific silencing of ASH2 or WDR5, by blocking the induction of CAMs, could affect the pathogenesis of HPH in mice. To achieve this goal, we harnessed an endothelium-targeting lentiviral delivery system in which the short hairpin RNA sequence was under the control of the Tie2 promoter/enhancer, whereas the viral envelope protein engineered to specifically recognize vascular endothelium. 25 Immunofluorescence staining revealed that mice injected with Endo-shAsh2 or Endo-shWdr5 showed specific knockdown of ASH2 or WDR5 in the endothelium (Figrue S10B). In contrast, neither fibroblast cells (delineated by FSP1; Figure S10C ) nor epithelial cells (labeled by SP-C; Figure S10D ) showed significant loss of ASH2/WDR5 expression. Of note, endothelial-specific targeting of either ASH2 or WDR5 dampened the elevation of right ventricular systolic pressure ( Figure 7A ) and right ventricular hypertrophy ( Figure 7B ) in hypoxia-challenged mice. Meanwhile, medial layer expansion and neomuscularization (Figure S11A-S11C) were less prominent in mice with endothelium depleted of ASH2 or WDR5.
In agreement of normalized HPH phenotype in mice, ASH2/WDR5 knockdown in the endothelium also suppressed the induction of ICAM-1, VCAM-1, and E-selectin at the mRNA level ( Figure 7C ) and the protein level ( Figure 7D ). Downregulation of CAM transactivation mirrored decreases in H3K4 dimethylation ( Figure 7E ) and trimethylation ( Figure 7F ) on the promoters. In accordance, adhesion of leukocytes to the pulmonary vessels was blocked ( Figure 7G ). Collectively, these data provide a functional link between ASH2/WDR5-mediated H3K4 methylation, CAM transactivation, and the pathogenesis of HPH in vivo.
Discussion
Persistent pulmonary inflammation, in which endotheliummediated recruitment of leukocytes plays a key role via the expression of adhesion molecules, has been observed in patients with HPH. 26 ,27 Yet, there has been no evidence that targeting any individual adhesion molecule could alleviate and stall the pathogenesis of HPH, suggesting that it might be the combinatory effect of a group of adhesion molecules that contributes to the progression of HPH. The current study delineates a novel epigenetic circuit underscoring the transcriptional activation of adhesion molecules in endothelial cells in response to hypoxic stress both in vitro and in vivo ( Figure 7F ), providing clues to the development of novel strategies against HPH.
Consistent with our previous finding that MKL1/MRTF-A is indispensable for oxidized low-density lipoproteininduced CAM activation in cultured endothelial cells, 12 our data as summarized here clearly portray MKL1/MRTF-A as a critical factor for vascular inflammation associated with HPH by virtue of connecting the epigenetic machinery to hypoxia-induced transactivation of adhesion molecules. The phenotype described here is consistent with a previously published rat model in which MKL1/MRTF-A was silenced by lentivirus-mediated delivery of short hairpin RNA.
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More importantly, endothelial-specific depletion of MKL1/ MRTF-A suppressed pulmonary inflammation and attenuated HPH in mice ( Figure S2 ), in agreement with our recent finding that endothelial MKL1/MRTF-A mediates angiotensin II-induced cardiac hypertrophy. 21 In light of our previous report that MKL1/MRTF-A is responsible for increased synthesis of endothelin in hypoxia-challenged cells, 20 these data collectively support the role of endothelial dysfunction, mediated by MKL1/MRTF-A, in the pathogenesis of HPH. MKL1/MRTF-A deficiency also significantly relieved hypoxia-induced elevation of left ventricular pressure and vascular remodeling. The current data set, however, should be interpreted with caution in defining the cell autonomous role for MKL1/MRTF-A as MKL1/MRTF-A is expressed not only in the vascular endothelium but also in other types of cells, including smooth muscle cells, fibroblast cells, and epithelial cells in the lungs in mice ( Figure S12 ). First, cytokines/ chemokines secreted by leukocytes fine-tune the proliferation and migration of smooth muscle cells. 3 Thus, diminished vascular remodeling in MKL1/MRTF-A knockout mice could presumably result from dampened leukocyte adhesion. Second, MKL1/MRTF-A is known to directly participate in the phenotypic modulation of smooth muscle cells, a process key to vascular remodeling in HPH. 29 In addition, correction of right ventricular hypertrophy could be explained by normalized pulmonary circulation and particularly restored endothelial function in the absence of MKL1/MRTF-A. An equally plausible explanation could be that MKL1/MRTF-A promotes ventricular hypertrophy by responding to pressure overload in the cardiomyocyte. 30 Third, MKL1/MRTF-A is known to regulate fibroblast to myofibroblast transition, 16, 31 a key process in HPH pathogenesis. 32 The possibility that MKL1/MRTF-A deficiency in fibroblast may stall fibroblast to myofibroblast transition and consequently HPH progression cannot be ruled out. Finally, the observation that MKL1/ MRTF-A interacts with NF-κB/p65 suggests that MKL1/ MRTF-A could also play a potential role in regulating the phenotype of circulating hematopoietic cells such macrophages and platelets in response to hypoxic stimulation. Indeed, our recent finding that MKL1/MRTF-A recruits the COMPASS complex to drive the expression proinflammatory mediators (eg, interleukin-1β) induced by lipopolysaccharide in macrophages seems to lend this model some support.
33
Given the universal expression pattern of MKL1/MRTF-A, these lingering ambiguities will have to be addressed using a tissue-specific MKL1/MRTF-A knockout model. MKL1/MRTF-A has been demonstrated to interact with multiple epigenetic factors, including chromatin remodeling proteins, 34 histone acetyltransferase, 17 and histone demethylase.
18 Downregulation of adhesion molecules as a result of MKL1/MRTF-A silencing was accompanied by the disappearance of acetylated histones H3 and H4, as well dimethylated and trimethylated H3K4 on the promoters of the corresponding genes. Of key importance, we have identified a histone H3K4 methyltransferase complex as part of the epigenetic machinery enlisted by MKL1/MRTF-A to activate adhesion molecules and to advance the pathogenic agenda imposed by hypoxic stress in mice. Germ-line deletion of either ASH2 or WDR5 results in developmental arrest and embryonic lethality. 23, 35 Our data indicate that endothelial-specific depletion of ASH2 or WDR5 in adult mice protected the mice from HPH. Hang et al 36 have reported that conditional knockout of Brg1, a chromatin remodeling protein necessary for vessel formation, in adult mice abrogates pressure overload-induced cardiac hypertrophy, a finding in line with our observation and echoing the assertion that inadvertent activation of developmentally critical factors may herald detrimental effects in postembryonic life.
Recently, several independent investigations have implicated H3K4 methylation in endothelial injury. In a string of publications, El-Osta and co-workers 37-39 have reported that H3K4 mono-, but not di-, or trimethylation, mediated by SET7, was responsible for p65 upregulation by hyperglycemic stress. On the contrary, Takizawa et al 40 suggest that induction of plasminogen activator inhibitor 1 in the endothelium in mice with type I diabetes mellitus was predominantly controlled by H3K4 trimethylation. Still, Zhong and Kowluru 41 note that repression of SOD2 expression by high glucose was synonymous with a reduction in H3K4 monomethylation and dimethylation. These seemingly conflicting data nonetheless argue for a role of H3K4 methylation in shaping the endothelial phenotype under stress conditions. Whereas hypoxia can modulate both global-and gene-specific H3K4 methylation in cancer cells, 42, 43 little is known about its effect on H3K4 methylation in endothelial cells and especially in the settings of HPH. Because single-gene-based epigenetic analysis tends to give limited and sometimes biased information toward the understanding of such complex disease states as HPH, a genome-wide survey of H3K4 methylation status before and after stress using chromatin immunoprecipitation-sequencing would greatly further our knowledge on the pathogenesis of HPH. In addition, it would be interesting to determine how MKL1/MRTF-A contributes to the makeup of H3K4 methylation in endothelial cells and more importantly how this process translates to a specific pathobiological process.
We have previously shown that hypoxia increases MKL1/ MRTF-A expression and nuclear localization in cultured endothelial cells and in the lungs in mice. 20 We show here that hypoxia promotes the recruitment of MKL1/MRTF-A to the CAM promoters, which is dependent on RhoA ( Figure S4 , S7, and S9). The RhoA-MKL1/MRTF-A axis plays important roles in cell and tissue injury. 12, 16, 44 Inhibition of the RhoA-ROCK signaling has been demonstrated to attenuate pulmonary hypertension in several different animal models although the underlying mechanism is ill-defined.
45-47 Our data as presented here indicate that RhoA is indispensible for hypoxia-induced CAM induction in endothelial cells ( Figure  S4 ). More intriguingly, RhoA silencing affects the disposition of modified histones on the CAM promoters by influencing MKL1/MRTF-A-dependent COMPASS recruitment (Figrues S7 and S9). These observations are consistent with a string of recent findings that seem to argue for a connection between cytoskeletal reorganization and epigenetic gene regulation.
48-50 Clearly, a thorough examination of RhoA-dependent epigenetic alterations across the genome would further our understanding of HPH pathogenesis and benefit a more rationalized exploitation of RhoA inhibitors in HPH intervention. A long held view is that the hypoxic response is intimately related to the inflammatory response in vivo 51 although there lacks unequivocal evidence whether a protein or a group of proteins can bridge these 2 responses. Our report here that MKL1/MRTF-A regulates pulmonary inflammation under hypoxic conditions seems to suggest that MKL1/MRTF-A might just be such as a moderator. In light of our previous reports that highlight the role of MKL1/MRTF-A in mediating the effects of oxidized low-density lipoprotein, 12 lipopolysaccharide, 33 and angiotensin II 21 and the fact that MKL1/ MRTF-A is universally expressed in the vasculature, this noncanonical pathway probably holds a key position during inflammatory situations within the vasculature.
Perspective
Our data lend support to a model wherein the transcriptional modulator MKL1/MRTF-A, through recruiting a histone H3K4 methyltransferase complex, acts as a switch turning on specific histone modifications to induce NF-κB-dependent CAM expression in endothelial cells. Future investigations building on these results will provide potential therapeutic solutions to the treatment of HPH. What Is New?
Sources of Funding
• We show here that (1) What Is Relevant?
• Elevated CAM in the vascular endothelium contributes to recruitment and adhesion of leukocytes and pulmonary inflammation, leading to the pathogenesis of HPH. Our data link MKL1/MRTF-A-dependent, epigenetic activation of CAM expression to endothelial dysfunction, pulmonary inflammation, and HPH. We expect that our findings will be of significant interest to a broad readership in the basic, clinical, and pharmaceutical communities.
Summary
Enhanced interaction between vascular endothelial cells and circulating leukocytes, as a result of transcriptional activation of cell adhesion molecules, helps establish a proinflammatory milieu contributing to the pathogenesis of chronic HPH. We report here that the transcriptional modulator MKL1/MRTF-A is responsible for recruiting a histone H3 lysine 4 methyltransferase complex to the CAM promoters to promote pulmonary inflammation and HPH pathogenesis. Endothelial-specific depletion of MKL1/MRTF-A or components of the COMPASS complex ameliorated HPH in mice. In conclusion, our data suggest that MKL1/MRTF-A, by coordinating key epigenetic alterations on CAM promoters, provides a critical link to hypoxia-induced endothelial malfunction and contributes to the pathogenesis of HPH. 8 . For expression plasmids, an empty vector was included as a control. For shRNA plasmids, a non-target plasmid was included as a control. A small amount of GFP plasmid (30ng/well) was always co-transfected with indicated constructs for monitoring and normalization of transfection efficiency. Luciferase activities were assayed 24-48 hours after transfection using a luciferase reporter assay system (Promega). Data were normalized by both protein concentration and GFP fluorescence and were expressed as arbitrary relative luciferase unit (RLU) compared with the control group.
Megakaryocytic leukemia 1 (MKL1) directs an H3K4 methyltransferase complex to regulate hypoxic pulmonary hypertension
Protein Extraction, Immunoprecipitation, and Western Blot
Whole cell lysates were obtained by re-suspending cell pellets in RIPA buffer (50 mM Tris pH7.4, 150 mM NaCl, 1% Triton X-100) with freshly added protease inhibitor tablet (Roche). Specific antibodies or pre-immune IgGs (P.I.I.) were added to and incubated with cell lysates overnight before being absorbed by Protein A/G-plus Agarose beads (Santa Cruz). Precipitated immune complex was released by boiling with 1X SDS electrophoresis sample buffer. Western blot analyses were performed with anti--actin (Sigma), anti-ICAM-1 (Abgent, AJ1386a), anti-VCAM-1 (Santa Cruz, sc-8304), and anti-E-selectin (Santa Cruz, sc-14011) antibodies.
RNA Isolation and Real-time PCR
RNA was extracted with the RNeasy RNA isolation kit (Qiagen). Reverse transcriptase reactions were performed using a SuperScript First-strand Synthesis System (Invitrogen). Real-time PCR reactions were performed on an ABI Prism 7500 system. Primers and Taqman probes used for real-time reactions were purchased from Applied Biosystems.
Mice
All protocols were approved by the intramural Committee on Ethic Conduct of Animal Studies. MKL1 knockout (KO) mice were obtained from Steve Morris's laboratory as previously described 9 . Female MKL1 KO mice have mammary epithelial deficiency rendering them unable to feed the cubs but are otherwise indistinguishable from wild type littermates under physiological conditions. 8-week old, male mice were housed in a low oxygen chamber (10% O 2 ) for three weeks to induce HPH. shRNA targeting, ASH2 (CGAGTCTTGTTAGCCCTACAT), or WDR5 (GCCGTTCATTTCAACCGTGAT) were cloned into an endothelium-specific expression vector (Tie2p/eas) and packaged using an endothelium-specific envelope (2.2) as previously described 10 . At week 1 and week 3, these mice were injected with lentivirus via tail vein. A similar endothelial-specific knockdown system targeting MKL1 has been described and validated recently 11 . Measurement of RVSP and heart weight was performed essentially as previously described 12 . Bronchoalveolar lavage (BAL) was collected from anesthetized mice using two 1-ml aliquots of PBS. Cells were centrifuged and resuspended in 1 ml PBS. Cells were used for flow cytometry and the BAL fluid (BALF) was used to analyze pro-inflammatory mediators by ELISA.
Histology
Immunohistochemistry was performed as previously described 13 . Briefly, parallel sections were blocked with 10% normal goat serum for 1 hour at room temperature and then incubated with anti--SMA (Sigma; 1:100). Staining was visualized by incubation with an appropriate biotinylated 2 o antibody and developed with a streptavidin-horseradish peroxidase kit (Pierce) for 20min. Sections were counterstained with hematoxylin. Pictures were taken using an Olympus IX-70 microscope. Vessel muscularity was determined using α-SMA-stained lung sections, with ~10 fields counted per animal. Vessels ≤ 50mm that were completely surrounded with -SMA were considered vascularized. Data are expressed as the percentage of total vessels.
Immunofluorescence staining
The plastic-embedded sections were incubated with primary antibodies, anti-CD31 (BD Biosciences), anti-ASH2 (Santa Cruz, sc-81184), anti-WDR5 (Santa Cruz, sc-135245), anti-CD3 (BD Biosciences, 554829), anti-CD45 (BD Biosciences, 610266), or anti-F4/80 (BD Biosciences, 552958), followed by incubation with donkey secondary antibodies (Jackson ImmunoResearch). The nuclei were counterstained with DAPI (Sigma). 
Leukocyte Adhesion Assay
Chromatin Immunoprecipitation (ChIP)
Chromatin was cross-linked with 1% formaldehyde. Cells were incubated in lysis buffer (150 mM NaCl, 25 mM Tris pH 7.5, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate) supplemented with protease inhibitor tablet. DNA was fragmented into 500 bp pieces using a 
Enzyme-linked immune absorbance assay (ELISA)
ELISA was performed using mouse lung homogenates and BALF to measure IL-1, IL-6, and MCP-1/CCL2 (Pierce).
Flow cytometry
Flow cytometry was performed as previously described using FACStar (Becton-Dickinson) with the following antibodies (eBioscience): FITC-labeled rabbit anti-mouse CD45, PE-labeled rat anti-mouse CD3, FITC-labeled rat anti-mouse F4/80.
Statistical analysis
Data are presented as mean±SD. For experiments concerning multiple groups, one-way ANOVA with post-hoc Scheffe analyses were performed to evaluate the differences. The differences between two (control and experimental) groups were determined by two-sided, unpaired Student's t-test. p values smaller than .05 are considered significant. For in vivo experiments, all p values are spelled out. Sample size for all animal experiments was between 3 to 5 per group while all in vitro experiments were repeated at least three times with a power analysis showing >80. and anti-SP-C (green) followed by counter-staining with DAPI. Arrows, typical epithelial cells with ASH2/WDR5 expression. 
